Company profile MCRB
There is not enough data for Seres Therapeutics near me to provide analysis
There is not enough data for Seres Therapeutics near me to provide correlation calculation
There is not enough data for Seres Therapeutics near me to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Seres Therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 9 | 28 211.1% QoQ | 13 -53.6% QoQ | 28 115.4% QoQ |
| 2020 | 10 11.1% YoY -64.3% QoQ | 16 -42.9% YoY 60.0% QoQ | 194 1392.3% YoY 1112.5% QoQ | 94 235.7% YoY -51.5% QoQ |
| 2021 | 59 490.0% YoY -37.2% QoQ | 70 337.5% YoY 18.6% QoQ | 51 -73.7% YoY -27.1% QoQ | 67 -28.7% YoY 31.4% QoQ |
| 2022 | 59 0.0% YoY -11.9% QoQ | 41 -41.4% YoY -30.5% QoQ | 55 7.8% YoY 34.1% QoQ | 78 16.4% YoY 41.8% QoQ |
| 2023 | 58 -1.7% YoY -25.6% QoQ | 114 178.0% YoY 96.6% QoQ | 30 -45.5% YoY -73.7% QoQ | 95 21.8% YoY 216.7% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Seres Therapeutics stock was 4.48 per week. The last year interest of Seres Therapeutics stock compared to the last 5 years has changed by 14.51%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 220.62%.
There is not enough data for Seres Therapeutics login to provide analysis
There is not enough data for Seres Therapeutics login to provide correlation calculation
There is not enough data for Seres Therapeutics login to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Seres Therapeutics news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 24 | 57 137.5% QoQ | 0 -100.0% QoQ | 134 inf% QoQ |
| 2020 | 18 -25.0% YoY -86.6% QoQ | 77 35.1% YoY 327.8% QoQ | 159 inf% YoY 106.5% QoQ | 82 -38.8% YoY -48.4% QoQ |
| 2021 | 45 150.0% YoY -45.1% QoQ | 46 -40.3% YoY 2.2% QoQ | 111 -30.2% YoY 141.3% QoQ | 105 28.0% YoY -5.4% QoQ |
| 2022 | 20 -55.6% YoY -81.0% QoQ | 176 282.6% YoY 780.0% QoQ | 127 14.4% YoY -27.8% QoQ | 59 -43.8% YoY -53.5% QoQ |
| 2023 | 153 665.0% YoY 159.3% QoQ | 132 -25.0% YoY -13.7% QoQ | 48 -62.2% YoY -63.6% QoQ | 95 61.0% YoY 97.9% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Seres Therapeutics news was 6.39 per week. The last year interest of Seres Therapeutics news compared to the last 5 years has changed by -17.21%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 28.09%.
There is not enough data for Seres Therapeutics CEO to provide analysis
There is not enough data for Seres Therapeutics CEO to provide correlation calculation
There is not enough data for Seres Therapeutics CEO to provide analysis
There is not enough data for Seres Therapeutics SEC filings to provide analysis
There is not enough data for Seres Therapeutics SEC filings to provide correlation calculation
There is not enough data for Seres Therapeutics SEC filings to provide analysis
There is not enough data for Seres Therapeutics clinical trials to provide analysis
There is not enough data for Seres Therapeutics clinical trials to provide correlation calculation
There is not enough data for Seres Therapeutics clinical trials to provide analysis
There is not enough data for Seres Therapeutics pipeline to provide analysis
There is not enough data for Seres Therapeutics pipeline to provide correlation calculation
There is not enough data for Seres Therapeutics pipeline to provide analysis
There is not enough data for Seres Therapeutics microbiome therapie to provide analysis
There is not enough data for Seres Therapeutics microbiome therapie to provide correlation calculation
There is not enough data for Seres Therapeutics microbiome therapie to provide analysis